Depressive symptoms increase risk of HIV disease progression and mortality among women in Tanzania

Journal of Acquired Immune Deficiency Syndromes

Volumn 44, Issue 4, 2007, Pages 470-477

  Antelman, Gretchen ^a   Kaaya, Sylvia ^b   Wei, Ruilan ^a   Mbwambo, Jessie ^b   Msamanga, Gernard I ^b   Fawzi, Wafaie W ^a   Smith Fawzi, Mary C ^c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Counseling; Depression; HIV disease progression; Pregnancy; Social support; Sub Saharan Africa; Tanzania

Indexed keywords

TRACE ELEMENT;

ADULT; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; COUNSELING; DEMOGRAPHY; DEPRESSION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PATIENT CARE; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PSYCHOSOCIAL CARE; PUERPERIUM; RISK ASSESSMENT; SCREENING; SOCIAL SUPPORT; SYMPTOM; TANZANIA; VERTICAL TRANSMISSION; WORLD HEALTH ORGANIZATION;

ADULT; DEPRESSIVE DISORDER; DISEASE PROGRESSION; EDUCATIONAL STATUS; EMPLOYMENT; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; MARITAL STATUS; PROPORTIONAL HAZARDS MODELS; QUESTIONNAIRES; RISK FACTORS; SURVIVAL ANALYSIS; TANZANIA; TIME FACTORS;

EID: 34147161711     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31802f1318     Document Type: Article

References (39)

1. UNAIDS Joint United Nations Program on HIV/AIDS (UNAIDS). 2006 report on the global AIDS epidemic. Available at: http:// www.UNAIDS.org. 2006. Last accessed November 1, 2006.
2. De Cock KM, Marum E, Mbori-Ngacha M. A serostatus-based approach to HIV/AIDS prevention and care in Africa. Lancet. 2003;362:1847-1849.
3. Leserman J. HIV disease progression: depression, stress and possible mechanisms. Biol Psychiatry. 2003;54:295-306.
4. Kopnisky KL, Stoff DM, Rausch DM. Workshop report: the effects of psychological variables on the progression of HIV-1 disease. Brain Behav Immun. 2004;18:246-261.
5. Weisse CS. Depression and immunocompetence: a reviewof the literature. Psychol Bull. 1992;111:475-489.
6. Glaser R, Rabin B, Chesney M, et al. Stress-induced immunomodulation: implications for infectious diseases? JAMA. 1999;281:2268-2270.
7. Evans DL, Leserman J, Perkins DO, et al. Stress-associated reductions of cytotoxic T lymphocytes and natural killer cells in asymptomatic HIV infection. Am J Psychiatry. 1995;152:543-550.
8. Murphy D, Gardner R, Greden JF, et al. Lymphocyte numbers in endogenous depression. Psychol Med. 1987;17:381-385.
9. Jackson JC, Cross RJ, Walker RF, et al. Influence of serotonin on the immune response. Immunology. 1985;54:505-512.
10. Irwin M, Gillin JC. Impaired natural killer cell activity among depressed patients. Psychiatry Res. 1987;20:181-182.
11. Black PH. Immune system-central nervous system interactions: effect and immunomodulatory consequences of immune system mediators on the brain. Antimicrob Agents Chemother. 1994;38:7-12.
12. Ammassari A, Trotta MP, Murri R, et al. Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature. J Acquir Immune Defic Syndr. 2002;31(Suppl 3):S123-S127.
13. Ickovics JR, Meade CS. Adherence to antiretroviral therapy among patients with HIV: a critical link between behavioral and biomedical sciences. J Acquir Immune Defic Syndr. 2002;31:98-102.
14. Coodley GO, Loveless MO, Nelson HD, et al. Endocrine dysfunction in the HIV wasting syndrome. J Acquir Immune Defic Syndr Hum Retrovirol. 1994;7:46-51.
15. Coodley GO, Loveless MO, Merrill TM. The HIV wasting syndrome: a review. J Acquir Immune Defic Syndr Hum Retrovirol. 1994b;7:681-694.
16. Cook JA, Grey D, Burke J, et al. Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women. Am J Public Health. 2004;94:1133-1140.
17. Kaharuza FM, Bunnel R, Moss S, et al. Depression and CD4 cell count among persons with HIV infection in Uganda. AIDS Behav. 2006;10 (Suppl):S105-S111.
18. Keogh P, Allen S, Almedal C, et al. The social impact of HIV infection on women in Kigali, Rwanda: a prospective study. Soc Sci Med. 1994;38:1047-1053.
19. Lyketsos CG, Hoover DR, Guccione M, et al. Depressive symptoms as predictors of medical outcomes in HIV infection. JAMA. 1993;270:2563-2567.
20. Perry S, Fishman B, Jacobsberg L, et al. Relationships over 1 year between lymphocyte subsets and psychosocial variables among adults with infection by human immunodeficiency virus. Arch Gen Psychiatry. 1992;49:396-401.
21. Jones DJ, Beach SRH, Forehand R, and the Family Health Project Research Group. Disease status in African American single mothers with HIV: The role of depressive symptoms. Health Psychol. 2001;20:417-423.
22. Zorrilla EP, McKay JR, Luborsky L, et al. Relation of stressors and depressive symptoms to clinical progression of viral illness. Am J Psychiatry. 1996;153:626-635.
23. Rabkin JG, Williams JBW, Remien RH, et al. Depression, distress, lymphocyte subsets, and human immunodeficiency virus symptoms on two occasions in HIV-positive men. Arch Gen Psychiatry. 1991;48:111-119.
24. Burack JH, Barrett DC, Stall RD, et al. Depressive symptoms and CD4 lymphocyte decline among HIV-infected men. JAMA. 1993;270:2568-2573.
25. Golub ET, Astemborski JA, Hoover DR, et al. Psychological distress and progression to AIDS in a cohort of injection drug users. J Acquir Immune Defic Syndr. 2003;32:429-434.
26. Ickovics JR, Hamburger ME, Vlahov D, et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women. JAMA. 2001;285:1466-1474.
27. Fawzi WW, Msamanga GI, Spiegelman D, et al. Rationale and design of the Tanzania vitamin and HIV infection trial. Control Clin Trials. 1999;20:75-90.
28. World Health Organization (WHO) International Collaborating Group for the Study of the WHO Staging System. Proposed World Health Organization staging system for HIV-infection and disease: preliminary testing by an international collaborative cross-sectional study. AIDS. 1993;7:711-718.
29. Derogatis LR, Lipman RS, Rickels K, et al. The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory. Behav Sci. 1974;19:1-15.
30. Hesbacher PT, Rickels K, Morris RJ, et al. Psychiatric illness in family practice. J Clin Psychiatry. 1980;41:6-10.
31. Kaaya SF, Fawzi MCS, Mbwambo JK, et al. Validity of the Hopkins Symptom Checklist-25 amongst HIV-positive pregnant women in Tanzania. Acta Psychiatr Scand. 2002;106:9-19.
32. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders - Non-Patient Edition (SCID-NP), version 2.0. New York: Biometrics Research Department, New York State Psychiatric Institute; 1995.
33. Broadhead WE, Gehlbach SH, deGruy FV, et al. The Duke-UNC functional social support questionnaire. Med Care. 1988;26:709-723.
34. Cox DR. Regression models and life-tables. J R Stat Soc [Ser B]. 1972;34:187-220.
35. Kelly JA, Murphy DA, Bahr GR, et al. Outcome of cognitive-behavioral and support group brief therapies for depressed, HIV-infected persons. Am J Psychiatry. 1993;150:1679-1686.
36. Bolton P, Bass J, Neugebauer R, et al. Group interpersonal psychotherapy for depression in rural Uganda. JAMA. 2003;289:3117-3124.
37. Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet. 1999;354:795-802.
38. Dabis F, Ekpini ER. HIV-1/AIDS and maternal and child health in Africa. Lancet. 2002;359:2097-2104.
39. Gaillard P, Melis R, Mwanyumba F, et al. Vulnerability of women in an African setting: lessons for mother-to-child HIV transmission prevention programmes. AIDS. 2002;16:937-939.